Pharmaceutical

WuXi XDC and AbTis collaborate on antibody-drug conjugates

WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.

Mar 13, 2025 - 06:00
WuXi XDC and AbTis collaborate on antibody-drug conjugates
WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.
Read the original article

Tags:

Previous Article

Canada and Alberta governments to invest in Entos R&D facility

Next Article

BMS to acquire longtime cell therapy partner 2seventy bio for $286m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Q1 2024 update: M&A activity in pharmaceutical in Sweden

May 21, 2024

Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate

Gail Wilensky on the Geisinger deal, the earnings bonan...

May 9, 2023

STAT+: Pharmalittle: German regulator eyes Ozempic export ban amid shortages; NIH-funded clinical trials lagging pharma’s in enrollment

STAT+: Pharmalittle: German regulator eyes Ozempic expo...

Nov 15, 2023